Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure

Bioorg Med Chem. 2008 Sep 15;16(18):8379-89. doi: 10.1016/j.bmc.2008.08.041. Epub 2008 Aug 26.

Abstract

The acyclic azanucleosides with 2-, 3-, or 4-aminobenzenesulfonyl function at the nitrogen atom of the sugar mimic were prepared by coupling of 2-, 3-, or 4-nitro-N-(2-pivaloyloxyethyl)-N-(pivaloyloxymethyl)benzenesulfonamide with the silylated pyrimidine nucleobases followed by the reduction of the nitro group with sodium dithionite in aqueous solution or the palladium-catalysed transfer hydrogenation. The azanucleosides were evaluated for, but found to be devoid of, activity against several RNA- and DNA-viruses in vitro.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / pharmacology*
  • Aza Compounds / chemical synthesis
  • Aza Compounds / pharmacology*
  • Catalysis
  • Cell Line
  • DNA Viruses / drug effects*
  • Drug Resistance, Viral
  • Humans
  • Hydrogenation
  • Nucleosides / chemical synthesis
  • Nucleosides / pharmacology*
  • Palladium / chemistry
  • Pyrimidine Nucleosides / chemistry
  • RNA Viruses / drug effects*
  • Structure-Activity Relationship
  • Sulfanilamide
  • Sulfanilamides / chemistry

Substances

  • Antiviral Agents
  • Aza Compounds
  • Nucleosides
  • Pyrimidine Nucleosides
  • Sulfanilamides
  • Sulfanilamide
  • Palladium